Associate Professor Corcoran is a urological surgeon and research scientist with an interest in the molecular drivers of lethal prostate cancer and novel treatments. Find out what drives him, where he’s come from and his hopes for the future of cancer care.
Olivia Newton-John will be remembered for much by many, but for me it is difficult to look past her enormous contribution to cancer research as a measure of impact.
Olivia’s generosity and leadership in fostering world-class cancer research will not be forgotten, and she has given Victoria an incredible and lasting asset in the Olivia Newton-John Cancer Research Institute.
Over more than 20 years, Professor Jonathan Cebon worked alongside Dame Olivia Newton-John AC OBE. The two became good friends and he witnessed her journey as advocate, champion and ultimately, patient, of the Olivia Newton-John Cancer Wellness and Research Centre.
Ms Jo Cockwill has been appointed the inaugural Deputy Chair of the VCCC Alliance Cancer Consumer Advisory Committee.
Since its inception in June 2022, the health equity program at the VCCC Alliance has gone from strength to strength. We are pleased to now be able to highlight some of our work on the VCCC Alliance website.
Dr Sarah Heynemann, a research fellow at St Vincent’s Hospital Melbourne, says the wisdom of those with a cancer diagnosis is humbling and a sage reminder that healthcare support should not just be about surviving, but thriving.
A paper published in the Internal Medicine Journal and led by former VCCC Alliance Research and Education Lead, Haematology, Professor Constantine Tam, has standardised testing for patients with mantle cell lymphoma.
Groundbreaking research that is improving screening and diagnoses for liver cancer has earned Associate Professor Jessica Howell the Inaugural Tony Burgess Medal awarded by the VCCC Alliance.
Back in March 2020, we established the Victorian COVID-19 Cancer Network in collaboration with Monash Partners Comprehensive Cancer Consortium. Almost two and a half years on, the Taskforce is still meeting regularly and remains resolutely solutions-focused in how to best support our patients and our workforce. This month, in the midst of this surge, we are focused on three main things.
Dr Dishan Herath, MBBS, FRACP, has been appointed the new Chair of the VCCC Alliance Cancer Research Advisory Committee.
The VCCC Alliance Board is delighted to announce that Associate Professor David Kok has been appointed as the new Chair of the VCCC Alliance Cancer Education and Training Advisory Committee (CETAC).
How a consumer transitions away from committee duties has significant implications for both organisation and consumer, so how do we as a sector ensure this transition process is as smooth as possible for all involved?
The role of consumer representatives within the Australian healthcare system has evolved significantly over past decades, with quality partnerships benefiting the community and those involved in advancing cancer research, education and clinical care. So, what exactly is a consumer in the cancer context?
NAIDOC Week provides the perfect opportunity for us as a society to reflect, engage and be inspired by First Nations people. In equal measure it’s a chance for us to recalibrate and align our efforts in striving for greater equity in cancer care and outcomes.
This year’s theme of NAIDOC Week Get Up! Stand Up! Show Up! calls for us to work collectively towards systemic change to support and secure institutional, structural, collaborative and cooperative reforms. I think this sentiment is directly transferrable into how we improve cancer care and outcomes for Indigenous people.
As we start another NAIDOC week, it is time to reflect and celebrate the achievements of Aboriginal and Torres Strait Islander people and communities. This year’s theme acknowledges the history of sustained activism in this country.
From the frontier wars and our earliest resistance fighters to our Aboriginal and Torres Strait Islander communities fighting for change today—we continue to show up. We cannot afford to lose momentum for change.
To celebrate NAIDOC Week, the VCCC Alliance hosted a special Monday Lunch Live centred on improving care for Aboriginal and Torres Strait Islander patients with advanced disease.
An expert panel featuring Professor Gail Garvey (GG), Abe Ropitini (AR), Clare O’Reilly (CO) and consumer Leah Lindrea-Morrison (LLM) discussed the more practical side of improving palliative care for Aboriginal patients with cancer in line with the Victorian Aboriginal cancer journey strategy.
Sarcoma is a rare and complex cancer (malignant tumour) arising from the bone, cartilage or soft tissues such as fat, muscle, connective tissue or blood vessels. Sarcomas can form anywhere in the body and are frequently hidden deep in the limbs. They are often misdiagnosed as a benign (non-cancerous) lump, or as a sporting injury or growing pains in young people.
It’s impossible to acknowledge the recent federal election result without also recognising the huge opportunity that comes with a new government, new leaders, and new members of our national parliament. A new government brings an injection of fresh perspectives on the hill in Canberra and a new opportunity to influence the key policies and directions nationally for cancer.
Content from the online Master of Cancer Sciences, jointly facilitated by the University of Melbourne and the VCCC Alliance, has beaten out the likes of Microsoft and Harvard Business School to claim gold in the international 2022 Telly Awards.
The VCCC Alliance has been awarded the ARCS 2022 Innovation Award (Organisation) for the SKILLED Clinical Trials Internship Program. The award acknowledges an organisation which showed creativity, resolve and resilience to solve what seemed like intractable issues in the face of the COVID-19 pandemic and beyond.
A series of five interactive educational webinars has been developed by Professor David Wiesenfeld, VCCC Alliance Research and Education Lead for Head and Neck Cancer, to address key questions in the management and treatment of tongue cancer under a multidisciplinary lens.
In 2018, the VCCC Alliance, supported by funding from the Victorian Government, led an innovative program to enable broader access to cancer clinical trials across regional areas, unimpeded by geographical location and local healthcare architecture. Four years down the track, this has been a game-changer.
In the complex world of health care, even a highly promising new treatment or potentially transformational protocol can be stymied. Implementation science brings proven theories, models and frameworks to the table to scaffold and support new ideas and help make them a reality.
Over time, clinical trials have become increasingly complex, creating barriers like travel distance, narrow eligibility criteria and technical/logistical gaps. The emerging trial methodologies of registry trials and teletrials challenge these barriers.
Melbourne MicroCert scholarships have been awarded to an impressive cohort of cancer clinicians, researchers, clinical trial study coordinators, postdoctoral scientists and PhD students from VCCC Alliance member organisations and beyond.